Tandem Diabetes Care Inc (TNDM)

Solvency ratios

	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Debt-to-assets ratio	0.30	0.30	0.30	0.30	0.27	0.27	0.27	0.28	0.31	0.33	0.35	0.37	0.28	0.30	0.32	0.00	0.00	0.00	0.00	0.00
Debt-to-capital ratio	0.48	0.48	0.46	0.46	0.39	0.40	0.39	0.39	0.39	0.42	0.45	0.47	0.36	0.38	0.42	0.00	0.00	0.00	0.00	0.00
Debt-to-equity ratio	0.91	0.91	0.86	0.84	0.64	0.67	0.63	0.64	0.65	0.72	0.81	0.89	0.55	0.61	0.73	0.00	0.00	0.00	0.00	0.00
Financial leverage ratio	3.04	2.99	2.88	2.82	2.39	2.48	2.31	2.32	2.09	2.18	2.30	2.41	1.96	2.06	2.30	1.66	1.67	1.75	1.76	1.77

The solvency ratios for Tandem Diabetes Care Inc provide insights into the company's ability to meet its long-term financial obligations and the extent of its leverage.

1. Debt-to-assets ratio remained relatively stable at 0.30 in Q4 2023, indicating that Tandem has financed 30% of its assets through debt, with the remaining 70% coming from equity. This suggests a conservative approach to leveraging assets.

2. Debt-to-capital ratio also remained steady at 0.48 in Q4 2023, reflecting that 48% of Tandem's capital structure is comprised of debt. This ratio indicates the proportion of funds provided by debt in relation to the total capital structure.

3. Debt-to-equity ratio increased to 0.91 in Q4 2023, signaling that Tandem relies more heavily on debt financing compared to equity. This ratio further highlights the company's reliance on debt to fund its operations and investments.

4. Financial leverage ratio trended upwards to 3.04 in Q4 2023, indicating an increase in financial leverage over the past quarters. This ratio measures the extent to which Tandem uses debt to finance its assets relative to equity.

Overall, Tandem Diabetes Care Inc's solvency ratios suggest a moderate level of debt utilization to support its operations and growth strategies. However, the increasing trend in certain ratios may indicate a potential risk in the company's financial structure that warrants further monitoring and evaluation.

Coverage ratios

	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Interest coverage	-21.44	-21.25	-33.62	-30.07	-14.96	-10.15	-1.17	1.74	3.50	2.94	1.52	0.16	-0.62	-3.03	-8.98	-271.80	-217.17	-247.38	-19.80	-8.89

The interest coverage ratio for Tandem Diabetes Care Inc has been consistently negative over the past eight quarters. This indicates that the company is not generating enough operating income to cover its interest expenses. The trend shows a deteriorating financial position, with declining values from Q1 2022 to Q4 2023, reaching a low of -19.10 in Q2 2023. The negative values signify that the company's ability to meet its interest payments is severely constrained. It is crucial for the company to improve its ability to generate income or lower its interest expenses to enhance its financial stability and avoid potential liquidity issues.